INSIGHTS ON CRITICAL ENVIRONMENTS

• Minimizing Particulate Risk

  While visible particles often draw immediate attention, visual inspection alone is insufficient, as subvisible particulate matter can pose equally significant risks to patient safety.

• What Your Biological Indicator Strategy Might Be Missing

  While biological indicators have long been the industry standard for evaluating bio-decontamination cycles, faster, cheaper, and quantifiable contamination detection technologies are emerging.

• Selecting A Platform Filter For High Concentration mAbs

  Read more about how Fujifilm Diosynth Biotechnologies evaluated a prime filter with challenging simulant solutions and how the experimental data confirmed superior performance, which demonstrated twice the throughput.

• How Robotic Isolator Technology Aligns To Annex 1 Principles

  Robotic gloveless isolators provide exceptional automation to eliminate human intervention and reduce contamination risk. Discover how they ensure compliance with the EU Annex 1 guideline to enhance sterility, precision, and monitoring.

• Equipment Life Cycle: It's A Commitment

  4/7/2026

  Progress depends on systems that grow with your work. Discover how end‑to‑end support keeps instruments running reliably, reduces long‑term risk, and ensures performance stays aligned with operations.

• How Modular Workflows Are Redefining CAR T Manufacturing

  7/30/2026

  Learn how flexible modular workflows can help manufacturers improve process adaptability, throughput, and control while preserving key CAR T quality attributes, including transduction efficiency.

• Minimizing Residue Build-Up In Cleanrooms

  10/15/2024

  Residues from cleaning agents can pose significant risks to cleanroom operations. Learn about residue management, measurement techniques, and best practices to ensure compliance and product safety.

• The Successful Implementation Of A New Aseptic Filling Line

  10/10/2024

  Discover how a Quality by Design approach can streamline the development of new sterile product filling lines, featuring a real-life example illustrating its effectiveness.

• A Risk-Based Decision Framework For Selecting Aseptic Barrier Technologies

  3/20/2026

  EU GMP Annex 1 requires a risk-based approach to selecting Isolators or RABS. This framework evaluates human intervention and decontamination to ensure robust sterility assurance.